Sub Category
Study Name
CALGB 80702: A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Patient must have completely resected tumors and at least one positive lymph node
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance